Holen Sie sich die Stockscreener-App
3.57
4.39%
0.15
Vorhandelsmarkt:
3.81
0.24
+6.72%
Schlusskurs vom Vortag:
$3.42
Offen:
$3.4
24-Stunden-Volumen:
49,077
Relative Volume:
0.38
Marktkapitalisierung:
$6.85M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+8.84%
1M Leistung:
+19.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$3.1501
$3.57
1-Wochen-Bereich:
$3.1501
$3.57
52-Wochen-Spanne:
$2.70
$8.86
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Vergleichen Sie QNTM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
3.57 | 6.85M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Quantum Biopharma Ltd Aktie (QNTM) Neueste Nachrichten
Contrasting Quantum Biopharma (NASDAQ:QNTM) & ASLAN Pharmaceuticals (NASDAQ:ASLN) - Defense World
Quantum BioPharma Closes Third Tranche Offering with Amended Terms - TipRanks
Quantum Biopharma in Court With Dr. Raza Bokhari on January 24 - WICZ
Quantum BioPharma Ltd - Stockhouse Publishing
Quantum BioPharma Advances Legal Actions Against Former CEO - TipRanks
Quantum BioPharma begins trading on Upstream a By Investing.com - Investing.com Nigeria
Quantum BioPharma Expands Global Reach with Upstream Listing - TipRanks
Quantum BioPharma begins trading on Upstream a - Investing.com
Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM - Index-Journal
Quantum BioPharma Expands Global Reach with Upstream Exchange Dual Listing for 2025 - StockTitan
Quantum Biopharma approved to dual list on Upstream - MSN
Quantum BioPharma to Dual List on Upstream - TipRanks
Quantum BioPharma to list on Upstream trading platform - Investing.com
Quantum Biopharma Ltd. Approved to Dual List on Upstream - AccessWire
How This $4 Stock Is Taking On Wall Street's Big Banks With A $700 Million Lawsuit - Barchart
Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency - Chronicle-Tribune
QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares Latest Stock News & Market Updates - StockTitan
Quantum BioPharma Takes a Bold Step into Cryptocurrency! This Could Change Everything! - YaNoticias
Biopharmaceutical company Quantum BioPharma reveals it bought $1 million worth of cryptocurrency - PANews
Quantum BioPharma Secures $500K in Fresh Capital Through Second Tranche Offering - StockTitan
Quantum Biopharma Announces Closing of Second Tranche - AccessWire
Quantum BioPharma adds $1m in Bitcoin to treasury, eyes future crypto financing - crypto.news
Quantum BioPharma Invests $1 Million in Bitcoin - PortalCripto
Quantum BioPharma Acquires $1M of Bitcoin and Other Cryptos By Investing.com - Investing.com Australia
Quantum BioPharma Acquires $1M of Bitcoin and Other Cryptos - Investing.com India
Quantum BioPharma Makes Bold $1M Bitcoin Investment, Embraces Crypto for Future Transactions - StockTitan
Quantum BioPharma Diversifies Treasury with the Purchase of - GlobeNewswire
Quantum BioPharma Makes Bold $1M Strategic Investment in Bitcoin, Crypto Assets - StockTitan
QNTM stock touches 52-week low at $3.48 amid market fluctuations - Investing.com Canada
How This $4 Stock is Taking on Wall Street's Big Banks with a $700 Million Lawsuit - Asianet Newsable
Quantum BioPharma Ltd. and HUGE Biopharma Australia Pty Ltd Announces the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS) - Marketscreener.com
Quantum BioPharma Closes First Tranche of Debenture Offering, Raises CAD $500,000 in Fresh Capital - StockTitan
Quantum Biopharma Announces Closing of First Tranche - AccessWire
Quantum BioPharma progresses with drug trial dosing By Investing.com - Investing.com South Africa
Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum Biopharma - The Eastern Progress Online
Quantum Biopharma Ltd (QNTM-Q) QuotePress Release - The Globe and Mail
Quantum BioPharma progresses with drug trial dosing - Investing.com
Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS) - AccessWire
Quantum BioPharma Advances Phase 1 Trial After Positive Safety Review of Novel Drug Candidate - StockTitan
Quantum BioPharma announces convertible debenture offering By Investing.com - Investing.com Nigeria
Quantum BioPharma Launches $5 Million Private Placement - TipRanks
Quantum BioPharma announces convertible debenture offering - Investing.com
Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million - AccessWire
Quantum BioPharma Ltd. announced that it expects to receive CAD 5 million in funding - Marketscreener.com
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Allege - Galveston County Daily News
Quantum BioPharma Ltd expected to post a loss of $3.90 a shareEarnings Preview - XM
Quantum BioPharma initiates phase 1 multiple sclerosis trial By Investing.com - Investing.com Canada
Quantum BioPharma sues CIBC and RBC seeking $700M in damages - MSN
Quantum BioPharma initiates phase 1 multiple sclerosis trial - Investing.com
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia - AccessWire
Finanzdaten der Quantum Biopharma Ltd-Aktie (QNTM)
Es liegen keine Finanzdaten für Quantum Biopharma Ltd (QNTM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):